Paratus Clinical is opening a new clinical research site in Northcote, Melbourne, expanding access to innovative therapies in Victoria.

The site focuses on psychiatric and psychological research alongside primary care trials. It brings expertise in pharmacological-assisted psychotherapy and includes purpose-built rooms for research with psychedelic compounds, working with academic institutions, healthcare providers and industry partners.

“This new research site represents an exciting step forward in advancing psychiatric and general clinical research.”
Professor Paul Fitzgerald

Leadership

  • Professor Paul Fitzgerald, psychiatrist, with 25 years of clinical trials experience including neurostimulation and novel pharmacological treatments.
  • Associate Professor Bernadette Fitzgibbon, formerly Deputy Director of the Monarch Research Institute, whose work focuses on new therapies for mental health and chronic pain.
  • Dr Yair Edinburg, full-time Principal Investigator for primary health trials, who also leads trials at our Western Sydney site.
“This marks an important milestone in our mission to bridge the gap between research and patient care.”
Matt Clacy, Chief Commercial Officer, Paratus Clinical